Latin American countries need to treat health spending as an investment rather than a cost if they are to expand coverage, ...

US healthcare major Johnson & Johnson (NYSE: JNJ) reported second-quarter 2026 sales of $25.31 billion, up 6.6% on the year, ...

India's Zydus Lifesciences has entered into a strategic deal to acquire select assets of Sterling Biotech, strengthening its ...

Cambridge, USA-based biotech Spero Therapeutics on Tuesday announced a $105 million non-recourse, non-dilutive royalty ...

Biogen (Nasdaq: BIIB) saw its shares fall 8% on Tuesday after a fuller look at mid-stage results for its experimental ...

US AI drug discovery firm Chai Discovery has raised $400 million in a Series C financing, valuing the San Francisco-based ...

Chai Discovery has signed a collaboration with Novartis (NOVN: VX) to use artificial intelligence in the discovery of ...

Japanese pharma major Takeda has agreed a multi-year collaboration with the Indonesian government to build the country’s ...

The biotech infrastructure sector has changed significantly since the biotechnology funding peak of 2021. Less venture ...

Medicines regulators in several major markets have issued a mix of approvals, safety communications, supply notices, ...

UK clinical-stage biotech Elevara Medicines today announced the appointment of Mai-Britt Zocca as chief executive (CEO), ...

Elevar Therapeutics, a majority-owned subsidiary of South Korea's HLB (Kosdaq: 028300), has received a complete response ...